Outcome of elderly patients with severe but asymptomatic aortic stenosis

Similar documents
Severe aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner

Spotlight on Valvular Heart Disease Guidelines

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons

Natural History and Echo Evaluation of Aortic Stenosis

Aortic Stenosis in the Elderly: Difficulties for the Clinician. Are Symptoms Due to Aortic Stenosis?

Aortic stenosis aetiology: morphology of calcific AS,

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery

What is the Role of Surgical Repair in 2012

Improving Quality of Care for Patients with Heart Valve Disease

Shahbudin H. Rahimtoola MB, FRCP, MACP, MACC, FESC, D.Sc. (Hon.)

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

TAVR in patients with. End-Stage CKD or in Renal Replacement Therapy:

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France

Exercise Testing/Echocardiography in Asymptomatic AS

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Severe symptomatic aortic stenosis is associated with a

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.

Severe Asymptomatic Aortic Stenosis

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Aortic valve implantation using the femoral and apical access: a single center experience.

The Ross Procedure: Outcomes at 20 Years

The operative mortality rate after redo valvular operations

Predictors of unfavorable outcome after atrial septal defect closure in adults

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

New Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?

Should early elective surgery be performed in patients with severe but asymptomatic aortic stenosis?

Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

The Role Of Decellularized Valve Prostheses In The Young Patient

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Decellularization of Aortic Homografts: South American and European Current Experience

Experience with 500 Stentless Aortic Valve Replacements

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Nothing to Disclose. Questions. Disclosure Asymptomatic Severe Aortic Stenosis: (When) Should One Intervene? Paul Wood at the Nathanson Lecture, 1958

Managing the Low Output Low Gradient Aortic Stenosis Patient

Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes

Risk Patients Before TAVI or AVR

Management of Difficult Aortic Root, Old and New solutions

Title:Relation Between E/e' ratio and NT-proBNP Levels in Elderly Patients with Symptomatic Severe Aortic Stenosis

David Dexter MD FACS Sentara Vascular Specialists Assistant Professor of Surgery EVMS. Peripheral Complications of TAVR

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris

Risk stratification of severe aortic stenosis according to new guidelines: long term outcomes

TAVR : Caring for your patients before and after TAVR

Bernard De Bruyne, MD, PhD Cardiovascular Center Aalst OLV-Clinic Aalst, Belgium

Clinical Outcome in Patients with Aortic Stenosis

Department of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden

Valvular Guidelines: The Past, the Present, the Future

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Long-term results (22 years) of the Ross Operation a single institutional experience

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

Reverse left atrium and left ventricle remodeling after aortic valve interventions

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

Role of a heart valve clinic programme in the management of patients with aortic stenosis

PREDICTORS OF OUTCOME IN SEVERE, ASYMPTOMATIC AORTIC STENOSIS PREDICTORS OF OUTCOME IN SEVERE, ASYMPTOMATIC AORTIC STENOSIS.

Intraoperative application of Cytosorb in cardiac surgery

Supplementary Appendix

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

The increase in the lifespan of the western population

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Cardiac catheterisation in AS

Comprehensive Echo Assessment of Aortic Stenosis

Quality Outcomes Mitral Valve Repair

The Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives. Martin B. Leon, MD

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

Aortic stenosis (AS) is common with the aging population.

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

EACTS Adult Cardiac Database

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery

First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always

A Health Care Professional s Guide Aortic Stenosis in Seniors

Simultaneous Aortic and Mitral Valve Replacement in Octogenarians: A Viable Option?

Dr.ssa Loredana Iannetta. Centro Cardiologico Monzino

Worldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates

30-Day Outcomes Following Implantation of a Repositionable Self-Expanding Aortic Bioprosthesis: First Report From the FORWARD Study

Valvular Intervention

ORIGINAL INVESTIGATION. Aortic Valve Replacement in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation

ESC / EACTS new valvular guidelines- Update

When Should I Order a Stress Test or an Echocardiogram

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR

Transcatheter aortic valve implantation and pre-procedural risk assesment

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

What the Cardiologist needs to know from Medical Images

Michigan Society of Echocardiography 30 th Year Jubilee

Adult Cardiac Surgery

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Transcription:

Outcome of elderly patients with severe but asymptomatic aortic stenosis Robert Zilberszac, Harald Gabriel, Gerald Maurer, Raphael Rosenhek Department of Cardiology Medical University of Vienna ESC Congress 2012 Munich, 27.08.2012

Conflict of interest None

Background Severe Asymptomatic AS in the Elderly Aortic stenosis (AS) is increasingly diagnosed in an ageing population An increased operative mortality and morbidity is expected in elderly patients and comorbidities are present frequently, making the decision to operate more difficult Symptom assessment is difficult in presence of comorbidities Elderly patients are underrepresented in most natural history studies on AS

Background Prospective Series on the Natural History of Asymptomatic Severe AS Author n = Average age Vmax (m/s) AVA (cm2) Otto, 1997 123 63±16 2.5 Rosenhek, 2000 128 60±18 4 Amato, 2001 66 50±15 1.0 Rosenhek, 2004 126 58±19 2.5 Das, 2005 125 65±9 1.4 Pelikka, 2006 622 72±11 4 Monin, 2009 211 72 [63 77] 3 1.5 Rosenhek, 2010 116 67±16 5 Kang, 2010 95 63±12 4.5 0.75 Maréchaux, 2010 135 64±15 1.5 Lancellotti, 2010 126 67±10 1.2

Aims To assess the natural history of severe asymptomatic aortic stenosis in a large cohort of elderly patients older than 70 years To identify potential predictors of outcome in these pts To define possible implications on the scheduling of follow up To define possible implications on the timing of intervention

Patients and methods All consecutive patients who were examined in our outpatient clinic for valvular heart disease when they had: severe asymptomatic aortic stenosis (AV Vel 4 m/s) Normal left ventricular function and were older than 70 years of age Exclusion criteria: Symptoms Additional hemodynamically significant valve lesion Previous cardiac surgery

Patient characterisitics 103 asymptomatic elderly patients according to these criteria Variable Gender (female) 51 Age (years) 77.3±4.8 Aortic jet velocity (m/s) 4.8±0.6 Aortic mean gradient (mmhg) 58±17 Aortic valve area (cm 2 ) 0.7±0.2 Coronary artery disease n (%) 31 (30 %) Hypertension n (%) 79 (77 %) Diabetes mellitus n (%) 19 (18 %) Hypercholesterinemia n (%) 40 (39 %) Baseline logistic EURO-Score (%) 7.2±4.1

Immobilizing comorbidities Impaired mobility Non-impaired mobility n=73 n=30 Osteoporosis, degenerative spinal disease (n=9) Arthrosis (n=8) History of trauma (n=3) Severe COPD (n=3) Idiopathic arthralgias (n=2) Peripheral artery disease (n=2) Rheumatoid arthritis (n=1) History of stroke (n=1) Reduced general condition (n=1)

Event-free survival Aortic Stenosis in the Elderly Event-free survival 1,0 0,9 0,8 91 events: Indication for aortic valve replacement (82) Cardiac deaths (9) 0,7 0,6 0,5 0,4 0,3 0,2 0,1 72% 42% 23% 1 2 3 Years

Indication for Surgery During follow-up, surgery was indicated in 82 pts (79,6%) because of the following reasons: Symptoms (75) Severe aortic valve calcification and rapid hemodynamic progression (3) Reduced left ventricular function (2) Prior to major noncardiac surgery in an asymptomatic patient (1) Primary indication for coronary artery bypass grafting (CABG) in another asymptomatic patient (1). Severe symptom onset (NYHA or CCS Class 2.5) was found in 32 patients (43% of patients that had developed symptoms) despite close follow-up. 71 of these patients underwent aortic valve replacement. 11 patients refused surgery. All patients received a biological valve prosthesis. 16 patients received concomitant aortocoronary bypass surgery.

Deaths 15 deaths in patients without indication for surgery: 9 cardiac deaths: In 4 of these patients, assessment of symptomatic status was obfuscated due to comorbidities Myocardial infarction (2) Cardiac decompensation with rapid deterioration (5) Pneumonia with multiorgan failure (2) 5 non-cardiac deaths: trauma (2), stroke (2) pancreatic cancer (1) and 1 unknown death In addition, 8 of the 11 patients who had refused surgery despite the development of progressive symptoms died after an interval of 2.5 (IQR 0.5 4.4) years: Cardiac decompensation (7) and sepsis (1)

Surgical Outcome There were five perioperative deaths: Aortic dissection (1), pneumonia (3), SIRS (1) 2 deaths in the early postoperative period (1 to 3 months after surgery): myocardial infarction and multiorgan failure (1) and bilateral pneumonia (1). 14 late postoperative deaths: cardiac decompensation (5), prosthetic valve endocarditis (1), myocardial infarction (1), pulmonary embolism (1), mediastinal carcinoma (1), metastatic colon carcinoma (1), trauma (2), unknown (2). Postoperative survival rates were 89±4%, 81±5%, 77±6% and 69±7% at 1,2,3 and 4 years respectively.

Event-free survival Aortic Stenosis in the Elderly Event-free survival according to peak aortic jet velocity 1,0 0,9 0,8 0,7 0,6 0,5 0,4 AV-Vel 4-5 m/s 0,3 0,2 0,1 p = 0.0007 AV-Vel 5 m/s Years 1 2 3

Event-free survival Aortic Stenosis in the Elderly Event-free survival according to age at baseline 1,0 0,9 0,8 0,7 0,6 Age < 80 y 0,5 0,4 0,3 0,2 0,1 p = 0.8 Age 80 y Years 1 2 3

Predictors of outcome Variable Univariate Multivariate p Risk Ratio p Risk Ratio Age 80 yrs n.s 0.9 (0.6-1.5) n.s 0.9 (0.6-1.5) Aortic jet velocity 5 m/s p = 0.0007 2.1 (1.3-3.3) p = 0.001 2.1 (1.3-3.2) Coronary artery disease p = 0.008 1.7 (1.0-2.7) p = 0.03 1.8 (1.1-2.8) Hypertension n.s 0.7 (0.4-1.2) n.s 0.8 (0.5-1.4) Diabetes n.s 0.7 (0.4-1.2) n.s 0.8 (0.4-1.3) Hypercholesteremia n.s 1.3 (0.8-2.1) n.s 1.0 (0.7-1.5)

Summary Elderly patients with severe aortic stenosis, despite being asymptomatic have a very high cardiac event rate and are at increased risk of cardiac death Severe symptom onset is common and the assessment of symptoms may be challenging in the presence of comorbidities Comorbidities making the detection of early symptoms difficult are frequent Surgical outcomes are good and risk stratification based on peak aortic jet velocity is helpful in these patients These findings may be helpful for the timing of surgery in this population

Thanks for your attention!